ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

ClinicalTrials.gov ID: NCT07298915

Public ClinicalTrials.gov record NCT07298915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 7:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT07298915
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Virginia
Other
Enrollment
24 participants

Conditions and interventions

Interventions

  • Exercise Behavioral
  • Tirzepatide Drug

Behavioral · Drug

Eligibility (public fields only)

Age range
30 Years to 65 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2026
Primary completion
Nov 30, 2026
Completion
May 31, 2027
Last update posted
Dec 22, 2025

2026 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Virginia Charlottesville Virginia 22901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07298915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07298915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →